Ellevest Inc’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Buy |
42,949
+14,612
| +52% | +$226K | 0.11% | 141 |
|
|
2025
Q1 | $421K | Sell |
28,337
-12,042
| -30% | -$179K | 0.03% | 221 |
|
|
2024
Q4 | $535K | Sell |
40,379
-38,549
| -49% | -$510K | 0.03% | 183 |
|
|
2024
Q3 | $1.12M | Buy |
78,928
+22,845
| +41% | +$325K | 0.06% | 98 |
|
|
2024
Q2 | $726K | Sell |
56,083
-22,156
| -28% | -$287K | 0.04% | 143 |
|
|
2024
Q1 | $1.09M | Buy |
78,239
+14,814
| +23% | +$206K | 0.07% | 89 |
|
|
2023
Q4 | $905K | Sell |
63,425
-13,156
| -17% | -$188K | 0.06% | 91 |
|
|
2023
Q3 | $1.18M | Buy |
76,581
+24,608
| +47% | +$381K | 0.09% | 59 |
|
|
2023
Q2 | $816K | Buy |
51,973
+9,619
| +23% | +$151K | 0.06% | 77 |
|
|
2023
Q1 | $698K | Buy |
42,354
+13,451
| +47% | +$222K | 0.05% | 86 |
|
|
2022
Q4 | $451K | Buy |
28,903
+21,050
| +268% | +$328K | 0.04% | 141 |
|
|
2022
Q3 | $102K | Sell |
7,853
-5,868
| -43% | -$76.2K | 0.01% | 414 |
|
|
2022
Q2 | $193K | Sell |
13,721
-17,264
| -56% | -$243K | 0.02% | 287 |
|
|
2022
Q1 | $444K | Buy |
30,985
+6,153
| +25% | +$88.2K | 0.04% | 150 |
|
|
2021
Q4 | $338K | Buy |
24,832
+2,008
| +9% | +$27.3K | 0.03% | 188 |
|
|
2021
Q3 | $374K | Buy |
22,824
+7,350
| +47% | +$120K | 0.04% | 143 |
|
|
2021
Q2 | $260K | Buy |
15,474
+292
| +2% | +$4.91K | 0.03% | 196 |
|
|
2021
Q1 | $277K | Buy |
15,182
+4,723
| +45% | +$86.2K | 0.03% | 146 |
|
|
2020
Q4 | $190K | Buy |
10,459
+1,923
| +23% | +$34.9K | 0.03% | 180 |
|
|
2020
Q3 | $152K | Buy |
8,536
+2,362
| +38% | +$42.1K | 0.03% | 164 |
|
|
2020
Q2 | $111K | Buy |
6,174
+2,990
| +94% | +$53.8K | 0.02% | 186 |
|
|
2020
Q1 | $48K | Buy |
3,184
+1,561
| +96% | +$23.5K | 0.01% | 236 |
|
|
2019
Q4 | $32K | Buy |
+1,623
| New | +$32K | 0.01% | 315 |
|